Reducing Melanoma Risk Through Genetic Testing
Melanoma Incidence and Genetic Connection
The American Cancer Society projects that 96,480 new cases of melanoma will be diagnosed in the United States in 2019, with approximately 7,200 fatalities expected from this condition. Over the past thirty years, the incidence rates of melanoma have been steadily increasing.
A significant portion of melanoma cases, around 10%, is believed to stem from heritable genetic mutations. The CDKN2A gene is one such high-risk gene linked to familial melanoma, with up to 40% of familial cases exhibiting mutations in this gene. Recent advancements in genetic testing have improved the identification of individuals carrying this specific mutation.
Impact of Genetic Testing on Sun Exposure
A recent study published in the journal *Genetics in Medicine* explored whether informing individuals about the presence of a gene mutation associated with an increased risk of melanoma could lead to reduced sun exposure. Conducted by researchers at the Huntsman Cancer Institute at the University of Utah, the study aimed to determine if a personalized warning based on genetic test results would be more effective in decreasing sun exposure compared to standard counseling.
Methodology of the Study
The research team targeted families with three or more members diagnosed with melanoma, recruiting participants aged 16 to 70. They divided the participants into two groups. Both groups received counseling about melanoma risks, a review of their family history, and advice on minimizing sun exposure.
The experimental group underwent genetic testing to determine if they carried a pathogenic mutation in the CDKN2A gene, while the control group did not receive testing and remained unaware of their genetic status. The researchers tracked changes in daily ultraviolet radiation (UVR) exposure, skin pigmentation, and sunburn occurrences over a one-year follow-up period.
Findings of the Study
The results revealed three distinct participant groups: carriers of the mutation (experimental group), non-carriers (experimental group), and the control group. Both carriers and control participants exhibited reduced UVR exposure after 12 months. Notably, carriers demonstrated a greater decrease in skin pigmentation, whereas non-carriers showed no significant change in UVR exposure.
These findings suggest that counseling is effective for both tested individuals who carry the mutation and those who do not undergo testing. However, non-carriers who received counseling did not alter their UVR exposure behavior, indicating that knowledge of not carrying the high-risk gene may diminish the impact of counseling.
Implications of the Study
The study’s results highlight the potential effectiveness of targeted genetic testing in promoting safer sun behaviors among high-risk individuals. However, it raises important questions regarding the implications of negative test results. If individuals are informed they do not carry the mutation, they may disregard counseling recommendations, leading to no change in UVR exposure.
Implementing a standard practice of testing everyone while only disclosing positive results could result in misconceptions for those not receiving feedback, as they might assume they tested negative. This scenario could inadvertently eliminate the behavioral benefits of genetic counseling.
Overall, the study underscores the importance of maximizing the positive behavioral changes in high-risk participants while addressing the challenges posed by negative test results. Further exploration is needed to enhance the effectiveness of risk-reduction strategies for all individuals.
References
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. *CA: a cancer journal for clinicians*. 2019;69(1):7-34.
2. Read J, Wadt KA, Hayward NK. Melanoma genetics. *J Med Genet*. 2016;53(1):1-14.
3. Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. *Cancer Res*. 2006;66(20):9818-28.
4. Stump TK, Aspinwall LG, Drummond DM, Taber JM, Kohlmann W, Champine M, et al. CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later. *Genetics in Medicine*. 2019.